Clinical Chronobiology: Circadian Rhythms in Health and Disease.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search methodology or primary quantitative data.
PubMed 39961369 · doi:10.1055/a-2538-3259
What was done
This narrative review summarizes the molecular mechanisms, physiology, diagnosis, and clinical implications of circadian rhythms in health and disease, focusing on the suprachiasmatic nucleus, core clock genes, circadian rhythm sleep-wake disorders, and associated systemic pathologies.
What was found
The abstract reports no quantitative metrics or statistical values. It describes how the suprachiasmatic nucleus synchronizes peripheral clocks via GABA, VIP, and clock genes (CLOCK, BMAL1, PER1-PER3, CRY1, CRY2). It notes that circadian disruptions manifest in at least six sleep-wake disorders diagnosed by history, diaries, and actigraphy, and are linked to metabolic syndrome, microbiome disruption, depression, neurodegenerative disorders, seizure timing in epilepsy, immune dysfunction, and cancer risk.
Why it matters
The review synthesizes how circadian misalignment affects multiple organ systems and highlights practical clinical interventions, including timed light exposure, melatonin agonists, and chronotherapy for drug delivery.
Limits
The abstract provides no empirical data, effect sizes, or confidence intervals. As a narrative review, it lacks a systematic literature search, risk-of-bias assessment, or details regarding the specific human study populations and sample sizes supporting these broad associations.
Cited by
- supports Intrinsically photosensitive retinal ganglion cells express melanopsin to drive the central circadian clock and cortisol regulation pathways.